The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks
By The Online Investor Staff, updated Sun., Aug. 19, 11:48 AM
| This Slide: #1 of 15 |
#15 of the Dow 30: Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a range of products in the health care field. Co. is organized into three business segments: Consumer, which includes a range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension; and Medical Devices, which includes products used in the orthopaedic, surgery, cardiovascular, diabetes care and eye health fields.
Johnson and Johnson SEC Filing Email Alerts Service
Open the JNJ Page at The Online Investor »
|
||||||||||||||||||||||||
Open the JNJ Page at The Online Investor (in a new window) »
JNJ Average Broker Rec.
 
|
Buy (3.00 out of 4) 38th percentile
(ranked lower than approx. 62% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
| Avg. Broker Rec.
|
Buy (3.00 out of 4) 38th percentile
(ranked lower than approx. 62% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
